Stefan D. Anker

Stefan D. Anker Stefan D. Anker is a German cariologist who is Head of Field “Tissue Homeostasis and Cachexia" at Charité University, Berlin, Germany. Previously, he was Professor of Innovative Clinical Trials at University Medical Center Göttingen in Germany. The main focus of the Innovative Clinical Trials department was research in the field of chronic heart failure, including the development and clinical testing of new therapies. Provided by Wikipedia
Showing 1 - 20 results of 69 for search 'Stefan D. Anker', query time: 0.11s Refine Results
  1. 1
    Once I get on a puzzle, I can't get off: Cachexia and wasting in 2018
    by Stephan vonHaehling, Stefan D. Anker
    Published 2018-12-01
    Get full text
    Article
  2. 2
    Anaemia, iron deficiency and heart failure in 2020: facts and numbers
    by Vijay K. Chopra, Stefan D. Anker
    Published 2020-10-01
    Get full text
    Article
  3. 3
    The Potential of Devices for HFpEF
    by Andrew J Stewart Coats, Stefan D Anker
    Published 2017-01-01
    Get full text
    Article
  4. 4
    Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference
    Get full text
    Article
  5. 5
    Open access efforts begin to bloom: ESC Heart Failure gets full attention and first impact factor
    by Stefan D. Anker, Stephan vonHaehling, Zoltan Papp
    Published 2019-10-01
    Get full text
    Article
  6. 6
    The Journal of Cachexia, Sarcopenia and Muscle in 2019
    Get full text
    Article
  7. 7
    Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia Conference
    Get full text
    Article
  8. 8
    The Management of Co-Morbidities in Patients with Heart Failure – Iron Deficiency
    Get full text
    Article
  9. 9
    Sleep-disordered breathing and cardiovascular disease
    Get full text
    Article
  10. 10
    COVID‐19: a major cause of cachexia and sarcopenia?
    Get full text
    Article
  11. 11
    Approach to the Treatment of Heart Failure With Preserved Ejection Fraction and Mid-Range Ejection Fraction
    by Ewa A Jankowska, Andrew JS Coats, Stefan D Anker
    Published 2017-01-01
    Get full text
    Article
  12. 12
    More variety with the Journal of Cachexia, Sarcopenia and Muscle: JCSM Clinical Reports and JCSM Rapid Communications have both gone live
    Get full text
    Article
  13. 13
    The (apparent) sacubitril/valsartan sex interaction in heart failure with preserved ejection fraction: not the result of relaxin effects but of BNP action?!
    Get full text
    Article
  14. 14
    Early initiation of SGLT2 inhibitors is important, irrespective of ejection fraction: SOLOIST‐WHF in perspective
    Get full text
    Article
  15. 15
    Time to jump on the bandwagon: the Journal of Cachexia, Sarcopenia and Muscle in 2018
    Get full text
    Article
  16. 16
    From meta‐analysis to Cochrane reviews
    Get full text
    Article
  17. 17
    Creating an impact, not an impression: ESC Heart Failure in its seventh year
    Get full text
    Article
  18. 18
    Effect of Carillon Mitral Contour System on patient‐reported outcomes in functional mitral regurgitation: an individual participant data meta‐analysis
    Get full text
    Article
  19. 19
    The Journal of Cachexia, Sarcopenia and Muscle stays the front‐runner in geriatrics and gerontology
    Get full text
    Article
  20. 20
    Heart failure prevalence in the general population: SOBOTA‐HF study rationale and design
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search